Publications by authors named "Shijian Da"

Claim this Profile
A
A real-world study of anlotinib combined with GS regimen as first-line treatment for advanced pancreatic cancer.
Gouling Zhan, Jianbing Hu, Shijian Da, Jie Weng, Chuanyi Zhou, Dahe Zhan

Front Endocrinol (Lausanne)ยท February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis